I
IDXG
Interpace Biosciences Inc
2.300
0.0000.00%Closed15:19 04/10 EDT
OPEN/PREV CLOSE2.100/2.300
TODAY RANGE2.100-2.300
VOL4.76K
MARKET CAP63.71M
52 WEEK RANGE0.522-2.380
AVG VOL (3M)5.57K
% TURNOVER0.02%
TURNOVER10.62K
P/E (TTM)-657.1429
% RANGE8.70%
EPS(TTM)-0.0035
P/E(FORWARD)0.499
P/B-34.1753
BVPS-0.0673
DIVIDEND--
P/S0.216
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.64M
SHARES OUTSTANDING27.70M
NEXT EARNINGS05/06-05/11
FREE FLOAT3.32M
LOT SIZE100
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·03/30 20:05
Interpace Biosciences GAAP EPS of $0.82, revenue of $9.22M
TipRanks·01/20 14:40
Interpace Diagnostics Guides 2026 Growth After Balance Sheet Cleanup
TipRanks·01/20 14:12
Interpace Biosciences sees FY25 revenue $38M-$39M
TipRanks·01/20 14:11
Interpace Biosciences sees FY26 revenue $40M
TipRanks·01/20 14:11
Interpace Biosciences announces preferred stock conversion
TipRanks·01/20 14:10
Interpace Biosciences to seek uplisting to Nasdaq Stock Market
TipRanks·12/03/2025 21:34
Interpace Biosciences Repays Loan Early for Growth
Seeking Alpha·11/13/2025 05:54
Interpace Biosciences GAAP EPS of $0.04, revenue of $8.76M
TipRanks·11/13/2025 03:59
Interpace Biosciences Reports Q3 2025 Earnings
TipRanks·09/15/2025 13:20
Interpace Biosciences presents two posters at ATA meeting
TipRanks·08/08/2025 06:09
Interpace Biosciences Reports Q2 2025 Earnings
Seeking Alpha·08/07/2025 21:39
Interpace Biosciences GAAP EPS of -$0.14, revenue of $9.2M
TipRanks·05/16/2025 04:18
Interpace Biosciences Reports Strong Q1 2025 Earnings
Seeking Alpha·05/09/2025 17:55
Interpace Biosciences GAAP EPS of $0.06, revenue of $11.5B